In our previous study, we showed that KITENIN (KAI1 C-terminal interacting tetraspanin) promotes the tumorigenic potential of cancers, and epidermal growth factor (EGF) stimulates KITENIN-mediated AP-1 activation [24]. The gene discussed is VANGL1; the disease is cancer.